Lion Point Capital »

Brooks Automation shares owned by Lion Point Capital

Quarter-by-quarter ownership of Brooks Automation (AZTA) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Brooks Automation

Tip: Access up to 7 years of quarterly data

All positions including Brooks Automation held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brooks Automation by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $323k 9.7k 33.26

More positions owned by Lion Point Capital

Milestone Pharmaceuticals (MIST)
Praxis Precision Medicines I Com New (PRAX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Benitec Biopharma Com New (BNTC)
Royalty Pharma Shs Class A (RPRX)
Geron Corporation (GERN)
Syndax Pharmaceuticals (SNDX)
Ardelyx (ARDX)
Cue Biopharma (CUE)
Disc Medicine (IRON)
Sarepta Therapeutics (SRPT)
Biohaven (BHVN)
Humacyte (HUMA)

View all positions for Lion Point Capital

Top funds holding Brooks Automation

BlackRock
Politan Capital Management
Vanguard Group
Dimensional Fund Advisors
State Street Corporation
Millennium Management
Jennifer Ranahan
Allspring Global Investments Holdings
Conestoga Capital Advisors
Congress Asset Management
Massachusetts Financial Services
Stephens Investment Management Group
Geode Capital Management
Luke P. La Valle, Jr.
Palisade Capital Management

View all funds holding Brooks Automation